Carcinogenesis Advance Access published online on July 29, 2004
Carcinogenesis, doi:10.1093/carcin/bgh245
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Comparative Carcinogenesis, National Cancer Institute at Frederick
* To whom correspondence should be addressed. E-mail: amaciag{at}mail.ncifcrf.gov.
K-ras is frequently mutated in lung adenocarcinomas. Recent discovery that wild-type K-ras is tumor suppressive in lung raises a question: how is mutant K-ras aggressively oncogenic? We hypothesized that mutant K-ras might lead to generation of reactive oxygen species and DNA damage, contributing to malignant transformation. We stably transfected human mutant K-rasV12 into nontransformed peripheral mouse lung epithelial cells (E10 line). Constitutively active mutant K-rasV12 in E10 cells led to a highly significant (P<0.001) increased level of peroxides, and a corresponding increase in amount of DNA strand-break damage, compared with the parental line E10 and the vector control. Levels of superoxide were not increased, suggesting a direct source of peroxides, such as cyclooxygenase 2 (COX-2). COX-2 protein and activity measured as prostaglandin E2 level were up-regulated in cells expressing mutant K-rasV12; COX-2 activity correlated with K-ras activity (K-ras p21-GTP). Both peroxide generation and DNA single strand breaks were significantly reduced by pre-treatment with COX- 2 specific inhibitor SC 58125, confirming COX-2 as the source of the reactive oxygen species. COX-2 has been repeatedly implicated in lung cancer, and is known to be regulated by ras and to release reactive oxygen species. Our data suggests that upregulation of COX-2, with consequent increase in peroxides and DNA damage, contributes to the dominant oncogenicity of mutant K-ras.
Revised June 24, 2004
Accepted July 21, 2004
CARCINOGENESIS
Mutant K-rasV12 increases COX-2, peroxides, and DNA damage in lung cells
2 Laboratory of Comparative Carcinogenesis, SAIC, NCI-Frederick
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Ray, K. R. Atkuri, D. Deb-Basu, A. S. Adler, H. Y. Chang, L. A. Herzenberg, and D. W. Felsher MYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species. Cancer Res., July 1, 2006; 66(13): 6598 - 6605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, S. Choudhary, O. Voznesensky, M. Mehrotra, M. Woodard, M. Hansen, H. Herschman, and C. Pilbeam Overexpression of Cox-2 in Human Osteosarcoma Cells Decreases Proliferation and Increases Apoptosis. Cancer Res., July 1, 2006; 66(13): 6657 - 6664. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. Yao, A. Maciag, C. J. Grubbs, R. A. Lubet, and M. You Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide. Mol. Cancer Ther., April 1, 2006; 5(4): 1060 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Daikoku, D. Wang, S. Tranguch, J. D. Morrow, S. Orsulic, R. N. DuBois, and S. K. Dey Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer Cancer Res., May 1, 2005; 65(9): 3735 - 3744. [Abstract] [Full Text] [PDF] |
||||

